A liquid biopsy can detect colorectal cancer at an early stage and with accuracy near 90%, according to research scheduled to be presented at the 2018 Gastrointestinal Cancers Symposium (January 18-20, 2018; San Francisco, CA).

News

By Megan Brooks

NEW YORK (Reuters Health) - A re-analysis of 2016 data from the U.S. Preventive Services Task Force (USPSTF) on colorectal cancer (CRC) screening indicates that flexible sigmoidoscopy reduces the risk of death, researchers say.

Read More

By Marilynn Larkin

NEW YORK (Reuters Health) – Systemic inflammation combined with sarcopenia could double the risk of death in patients with colorectal cancer (CRC), suggesting that these markers have clinical predictive value, researchers say.

Read More

By Lorraine L. Janeczko

NEW YORK (Reuters Health) - For patients with complications after colorectal surgery, being readmitted to the same medical center and being cared for by the surgeon who performed the operation may increase the likelihood of survival, data from New York State suggest.

Read More

Research in Review

Over-the-counter heartburn and gastrointestinal drugs, such as proton pump inhibitors (PPIs), may decrease the effectiveness of chemotherapy in patients with gastroesophageal cancer (GEC), according to a new study published in JAMA Oncology.

-----

Related Content

Read More

The recently published US Preventative Services Task Force (USPSTF) updated recommendation statement on colorectal cancer screening referenced multiple available options for colorectal screening, including Epigenomics’ Epi proColon.

Read More

Patients with stage II or stage III rectal cancer may have better outcomes when treated with surgery and chemoradiotherapy than those who receive chemoradiotherapy alone, according to an article published in JAMA Oncology.

Read More

There is no benefit from the addition of bevacizumab to capecitabine in the adjuvant setting for colorectal cancer, according to results from a clinical trial.

Read More

Subscribe to Colorectal Cancer